NCT03291366

Mesenchymal Stem Cells in Central Nervous System injury2017

Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System injury2017

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Fuzhou General Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Central nervous system (CNS) injury leads to morbidity in patients, which has few good rehabilitation measures. Mesenchymal stem cells seem to have regenerative and tissue-repairing capabilities. The investigators design this study to infuse mesenchymal stem cells (MSCs) intrathecally to CNS injury patients, and observe the safety and efficacy by recording the change of nervous system scores, trying to prove the effect of MSC in rehabilitate CNS injury.

Conditions

• Central Nervous System Injury

Interventions

Type	Name	Description
DRUG	UCMSCC	infusion of aUCMSC and conventional therapy
DRUG	conventional treatment	conventional treatment

Timeline

• Start date: 2017-01-01
• Primary completion: 2020-01-01
• Completion: 2022-01-01
• First posted: 2017-09-25
• Last updated: 2017-09-25